Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/30195
DC FieldValueLanguage
dc.contributor.authorVelkoska Nakova, Valentinaen_US
dc.contributor.authorKrstevska, Brankicaen_US
dc.contributor.authorSrbinovska Kostovska, Elizabetaen_US
dc.contributor.authorGeorgievska Ismail, Ljubicaen_US
dc.contributor.authorVolkanovska Ilijevska, Cvetankaen_US
dc.contributor.authorMilenkovikj, Tatjanaen_US
dc.date.accessioned2024-05-17T07:03:16Z-
dc.date.available2024-05-17T07:03:16Z-
dc.date.issued2024-05-06-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/30195-
dc.description.abstractBackground: Treatment of subclinical hypothyroidism (ScH) when TSH is between the upper reference value and 7mU/L, especially in patients younger than 65 years is controversial. Objectives: To compare the risk factors for atherosclerosis and echocardiographic parameters in patients with ScH1 (4, 2≤TSH≤7mU/L) to euthyroid subjects and patients with ScH2 (TSH>7mU/L). Material and Methods: Prospectively 54 consecutive patients with newly diagnosed ScH (19 with TSH≤7mU/L (ScH1) and 35 with TSH>7mU/L (ScH2)) started for the first time with levothyroxine therapy, and 30 healthy subjects were recruited from the outpatient department of the University Clinic of Endocrinology in Skopje, R. of N. Macedonia. Laboratory analyses and an echocardiography study were done at the first visit and after 5 months in a euthyroid stage in patients with ScH. Results: The mean age and TSH value in ScH group were 43.1±12.4y., and 8.71± 1, 9mU/L. Compared to healthy controls, patients with ScH1 had a higher mean triglycerides and non-HDL-C ratio (1.52±0.9 vs 1.1±0.6, and 4.3±1.1 vs 3.79±0.9, P<0.05), lower E/A ratio (1.05 ± 0.25 vs 1.26 ± 0.36, P<0.05), higher E/e’ sep. ratio (8.56 ± 2.63 vs 6.04 ± 1.64, P< 0.01), higher myocardial performance index (MPI) (0.47 ± 0.09 vs 0.43 ± 0.07, P< 0.05), lower global longitudinal strain (GLS) (-19.34 ± 2.0 vs -20.9 ± 1.7%, P< 0.05), and lower S wave derived by tissue Doppler imaging (0.074 ± 0.01 vs 0.092 ± 0.01 m/s, P< 0.01). Compared to ScH2, patients with ScH1 have lower GLS but without statistical significance. Levothyroxine treatment (L-T4T) in patients with ScH1 contributed to higher EF (61.9 ± 5.2 vs 63.1 ± 4.6%, P< 0.05), lower E/e’ sep. ratio (8.56 ± 2.63 vs 7.21 ± 2.23, P< 0.05), and lower MPI (0.47 ± 0.09 vs 0.43 ± 0.05%, P< 0.05), compared to values in ScH1 patients at baseline. The same parameters were improved in the ScH2 group after L-T4T. Conclusions: In a small study, patients with ScH1 vs healthy individuals had subtle changes in certain parameters that indicate involvement of diastolic function of the left ventricle in ScH, and these parameters improved after L-T4T.en_US
dc.language.isoenen_US
dc.publisherBioscientificaen_US
dc.relation.ispartofEndocrine Abstractsen_US
dc.subjectdiastolic functionen_US
dc.subjectsubclinical hypothyroidismen_US
dc.titleEchocardiographic differences between the mild form of subclinical hypothyroidism and healthy subjectsen_US
dc.typeProceeding articleen_US
dc.relation.conference26th European Congress of Endocrinology 2024en_US
dc.identifier.doi10.1530/endoabs.99.p384-
dc.identifier.urlhttp://www.endocrine-abstracts.org/ea/0099/ea0099P384-
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
ece2024_abstractbook.pdf10.73 MBAdobe PDFView/Open
ece2024_abstractbook.pdf10.73 MBAdobe PDFView/Open
Show simple item record

Page view(s)

114
checked on Sep 22, 2024

Download(s)

31
checked on Sep 22, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.